Intravenous immunoglobulin for treatment of mild-to-moderate Alzheimer's disease: a phase 2, randomised, double-blind, placebo-controlled, dose-finding trial
Dodel, Richard, Rominger, Axel, Bartenstein, Peter, Barkhof, Frederik, Blennow, Kaj, Förster, Stefan, Winter, Yaroslav, Bach, Jan-Philipp, Popp, Julius, Alferink, Judith, Wiltfang, Jens, Buerger, KathVolume:
12
Language:
english
Journal:
The Lancet Neurology
DOI:
10.1016/S1474-4422(13)70014-0
Date:
March, 2013
File:
PDF, 746 KB
english, 2013